Law360, New York (April 1, 2010, 12:00 PM EDT) -- A federal judge has signed off on a $20 million settlement between Eli Lilly & Co. and the state of Louisiana in the multidistrict product liability litigation over Eli Lilly's off-label promotion of its antipsychotic Zyprexa, the latest in a string of the drugmaker's deals with state attorneys general.
The consent judgment entered in the U.S. District Court for the Eastern District of New York on Wednesday leaves Eli Lilly off the hook for any admission of wrongdoing.
The deal resolves the Louisiana attorney general's investigation...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.